clinical trial · NCT06716775
Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd·N/A·not yet recruiting·n = 200
NSCLC Brain MetastasisTumor treating felds (TTF)Best Standard of Care
brief summary
This is a randomized, controlled, open-label, phase III trials. The main purpose of this study is to evaluate the effectiveness and safety of tumor treating felds (TTF) combined with stereotactic radiosurgery (SRS) in the treatment of brain metastases from non-small cell lung cancer (NSCLC) .
started
Dec 20, 2024
primary completion
Jun 30, 2028
completion
Oct 30, 2028
last updated
Dec 4, 2024
official title
Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer: a Randomized, Controlled, Open-label Study.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol